UnitedHealth Group (UNH) FY2025 10-K Annual Report
UnitedHealth Group (UNH) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Mar 2, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
UnitedHealth Group FY2025 10-K Analysis
Business Overview
- • Dual-segment model: UnitedHealthcare (health benefits) + Optum (health services/tech), serving payers, providers, patients, and governments
- • Major leadership overhaul: new CEO (Hemsley, May 2025), CFO (DeVeydt, Sept 2025), UHC CEO (Noel, Jan 2025), and Optum CEO (Conway, May 2025) — near-complete C-suite reset
- • CMS premium revenue = 44% of total consolidated revenues, dominated by UnitedHealthcare Medicare & Retirement's 8.4M Medicare Advantage members
- • Optum Rx managed $188B in pharmaceutical spending in 2025, including ~$87B in specialty pharma, across ~64,000 retail pharmacies
- • Optum Insight backlog declined to $31.1B from $32.8B YoY; Jan 2026 realignment moved Optum Financial (~26M accounts, $27B AUM) from Optum Health into Optum Insight
Management Discussion & Analysis
- • Revenue $447.6B, up 12% YoY ($47.3B increase); UnitedHealthcare +16% to $344.9B; Optum +7% to $270.6B
- • Operating margin collapsed to 4.2% vs 8.1% prior year; MCR deteriorated to 89.1% vs 85.5%; net earnings margin 2.7% vs 3.6%
- • Best segment: Optum Rx revenue +$21.5B to $154.7B, operating margin 4.6% vs 4.4%; worst: Optum Health swung to -0.3% operating margin from +7.4%, losing $278M vs earning $7.8B
- • Operating cash flow $19.7B vs $24.2B; capex $3.6B; dividends $7.9B; buybacks $5.5B vs $9.0B prior year
- • Management expects Medicare Advantage and Medicaid membership contraction in 2026; 2027 Medicare Advantage rate notice "far below" medical cost trend; $2.5B restructuring charge signals significant ongoing cost pressure
Risk Factors
- • Change Healthcare cyberattack (2024) exposed protected health information/PII; recently acquired non-integrated systems flagged as heightened ongoing vulnerability
- • Goodwill and intangible assets $131B = 42% of total consolidated assets; impairment risk if acquired businesses underperform assumptions
- • Medicare Advantage benchmark cuts by CMS ongoing; star ratings below 4 stars disqualify plans from quality bonus payments affecting benefits competitiveness
- • FTC/DOJ antitrust enforcement actions previously brought against UHG; explicitly cited as barrier to completing future strategic acquisitions
- • Premium revenues from risk-based products ~80% of total consolidated revenues; small utilization rate variances cause material financial swings
UnitedHealth Group FY2025 Key Financial MetricsXBRL
Revenue
$447.6B
▲ +11.8% YoY
Net Income
$12.1B
▼ -16.3% YoY
Operating Margin
4.2%
▼ -383bp YoY
Net Margin
2.7%
▼ -91bp YoY
ROE
12.0%
▼ -261bp YoY
Total Assets
$309.6B
▲ +3.8% YoY
EPS (Diluted)
$13.23
▼ -14.7% YoY
Operating Cash Flow
$19.7B
▼ -18.6% YoY
Source: XBRL data from UnitedHealth Group FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other UnitedHealth Group Annual Reports
Get deeper insights on UnitedHealth Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.